Eli Lilly Fires Off Another Cymbalta Patent Suit
Eli Lilly and Co. has continued its effort to stop generic-drug companies from marketing copycat versions of the antidepressant Cymbalta, shooting off a patent infringement suit against India-based Sun Pharmaceutical Industries...To view the full article, register now.
Already a subscriber? Click here to view full article